These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37915478)

  • 41. The next generation of synthetic cannabinoids: Detection, activity, and potential toxicity of pent-4en and but-3en analogues including MDMB-4en-PINACA.
    Krotulski AJ; Cannaert A; Stove C; Logan BK
    Drug Test Anal; 2021 Feb; 13(2):427-438. PubMed ID: 32997377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICA.
    Kevin RC; Lefever TW; Snyder RW; Patel PR; Fennell TR; Wiley JL; McGregor IS; Thomas BF
    Forensic Toxicol; 2017; 35(2):333-347. PubMed ID: 28824730
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of the synthetic cannabinoid XLR-11 on the viability and migration rates of human brain microvascular endothelial cells in a clinically-relevant model.
    Al-Eitan L; Alhusban A; Alahmad S
    Pharmacol Rep; 2020 Dec; 72(6):1717-1724. PubMed ID: 32632915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
    Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
    Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The expression analyses of GSK3B, VEGF, ANG1, and ANG2 in human brain microvascular endothelial cells treated with the synthetic cannabinoid XLR-11.
    Al-Eitan L; Alahmad S
    Gene; 2023 Aug; 878():147585. PubMed ID: 37355149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of a new tert-leucinate class synthetic cannabinoid in powder and "spice-like" herbal incenses: Methyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate (5F-MDMB-PICA).
    Risseeuw MDP; Blanckaert P; Coopman V; Van Quekelberghe S; Van Calenbergh S; Cordonnier J
    Forensic Sci Int; 2017 Apr; 273():45-52. PubMed ID: 28214755
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transesterification of Indazole-3-carboxamide Synthetic Cannabinoids: Identification of Metabolite Biomarkers for Diagnosing Co-abuse of 5F-MDMB-PINACA and Alcohol.
    Wang Z; Fong CY; Goh EML; Moy HY; Chan ECY
    J Anal Toxicol; 2023 Jan; 46(9):1016-1024. PubMed ID: 34918103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of Liver Size Reduction in Zebrafish Larvae by the Emerging Synthetic Cannabinoid 4F-MDMB-BINACA and Its Impact on Drug Metabolism.
    Park YM; Dahlem C; Meyer MR; Kiemer AK; Müller R; Herrmann J
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxic by design? Formation of thermal degradants and cyanide from carboxamide-type synthetic cannabinoids CUMYL-PICA, 5F-CUMYL-PICA, AMB-FUBINACA, MDMB-FUBINACA, NNEI, and MN-18 during exposure to high temperatures.
    Kevin RC; Kovach AL; Lefever TW; Gamage TF; Wiley JL; McGregor IS; Thomas BF
    Forensic Toxicol; 2019 Jan; 37(1):17-26. PubMed ID: 30705707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism studies of 4'Cl-CUMYL-PINACA, 4'F-CUMYL-5F-PINACA and 4'F-CUMYL-5F-PICA using human hepatocytes and LC-QTOF-MS analysis.
    Stalberga D; Ingvarsson S; Bessa G; Maas L; Vikingsson S; Persson M; Norman C; Gréen H
    Basic Clin Pharmacol Toxicol; 2023 Mar; 132(3):263-280. PubMed ID: 36544361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Respiratory failure in confirmed synthetic cannabinoid overdose.
    Manini AF; Krotulski AJ; Schimmel J; Allen L; Hurd YL; Richardson LD; Vidal K; Logan BK
    Clin Toxicol (Phila); 2022 Apr; 60(4):524-526. PubMed ID: 34499005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection of the recently emerged synthetic cannabinoid 4F-MDMB-BINACA in "legal high" products and human urine specimens.
    Haschimi B; Mogler L; Halter S; Giorgetti A; Schwarze B; Westphal F; Fischmann S; Auwärter V
    Drug Test Anal; 2019 Sep; 11(9):1377-1386. PubMed ID: 31228224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of phase-I and phase-II metabolites and the metabolic pathway of the novel synthetic cannabinoid 5F-EDMB-PICA in vitro.
    Gao Y; Shi K; Wang P; Liu X; Liu C; Luo L; Lin Y; Yang L; Yang R; Liao L
    Arch Toxicol; 2024 Jul; ():. PubMed ID: 38955863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
    Banister SD; Adams A; Kevin RC; Macdonald C; Glass M; Boyd R; Connor M; McGregor IS; Havel CM; Bright SJ; Vilamala MV; Lladanosa CG; Barratt MJ; Gerona RR
    Drug Test Anal; 2019 Feb; 11(2):279-291. PubMed ID: 30151911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human phase-I metabolism and prevalence of two synthetic cannabinoids bearing an ethyl ester moiety: 5F-EDMB-PICA and EDMB-PINACA.
    Giorgetti A; Brunetti P; Haschimi B; Busardò FP; Pelotti S; Auwärter V
    Drug Test Anal; 2023 Mar; 15(3):299-313. PubMed ID: 36366743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A subtle structural modification of a synthetic cannabinoid receptor agonist drastically increases its efficacy at the CB1 receptor.
    Yano H; Chitsazi R; Lucaj C; Tran P; Hoffman AF; Baumann MH; Lupica CR; Shi L
    bioRxiv; 2023 Jun; ():. PubMed ID: 37398099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons.
    Rodrigues TB; Souza MP; de Melo Barbosa L; de Carvalho Ponce J; Júnior LFN; Yonamine M; Costa JL
    Forensic Toxicol; 2022 Jan; 40(1):119-124. PubMed ID: 36454481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of the synthetic cannabinoid 5F-PY-PICA by human and rat hepatocytes and identification of biliary analytical targets by directional efflux in sandwich-cultured rat hepatocytes using UHPLC-HR-MS/MS.
    Mardal M; Annaert P; Noble C; Oorts M; Linnet K
    J Pharm Biomed Anal; 2018 Feb; 149():296-307. PubMed ID: 29128830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation.
    Fujiyama S; Matsubara H; Nozawa Y; Maruyama K; Mori Y; Tsutsumi Y; Masaki H; Uchiyama Y; Koyama Y; Nose A; Iba O; Tateishi E; Ogata N; Jyo N; Higashiyama S; Iwasaka T
    Circ Res; 2001 Jan; 88(1):22-9. PubMed ID: 11139469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.